Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial
JavaScript is disabled for your browser. Some features of this site may not work without it.
Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial
S, Jessan; S, Saleem; MK, Hoffman; SS, Goudar; RJ, Derman; JL, Moore; A, Garces; L, Figueroa; NF, Krebs; J, Okitawutshu; A, Tshefu; CL, Bose; M, Mwenechanya; E, Chomba; WA, Carlo; PK, Das; A, Patel; PL, Hibberd; F, Esamai; EA, Liechty; S, Bucher; TL, Nolen; M, Koso-Thomas; M, Miodovnik; EM, McClure; RL, Goldenberg
Limited data are available from low- and middleincome countries (LMICs) on the relationship of haemoglobin
levels to adverse outcomes at different times during pregnancy.
We evaluated the association of haemoglobin levels in
nulliparous women at two times in pregnancy with pregnancy
outcomes